Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Alan D. Tice"'
Publikováno v:
International Journal of Medical Sciences, Vol 7, Iss 1, Pp 36-42 (2010)
OBJECTIVE: To identify apparent adverse effects of treatment of chronic hepatitis C and their relationship to sustained virologic response (SVR). METHODS: A retrospective study was conducted of all Hepatitis C virus (HCV)-infected patients treated wi
Externí odkaz:
https://doaj.org/article/22a4197fb554412283f79e16845464ee
Autor:
Alan D Tice
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 11, Iss Suppl A, Pp 45A-48A (2000)
Externí odkaz:
https://doaj.org/article/3d5adc09ff924f0eb23dc51a71490487
Autor:
Alan D Tice
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 11, Iss Suppl A, Pp 17A-21A (2000)
Externí odkaz:
https://doaj.org/article/cb7507f0576d4364948d1e71e3fa419a
Autor:
Alan D. Tice
Publikováno v:
Clinical Infectious Diseases. 54:S239-S243
Oritavancin is a new antibiotic for the treatment of serious infections with Gram-positive bacteria. It has been shown to be effective against methicillin-susceptible and -resistant Staphylococcus aureus as well as enterococci. With a terminal half-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7724cd37524b03d1f90f4cbaa541847
https://doi.org/10.1093/cid/cir1047
https://doi.org/10.1093/cid/cir1047
Autor:
Thana Khawcharoenporn, Alan D. Tice
Publikováno v:
The American Journal of Medicine. 123:942-950
Limited data exist on optimal empiric oral antibiotic treatment for outpatients with cellulitis in areas with a high prevalence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) infections.We conducted a 3-year retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8de409709987da30ec85a6fbb15d600
https://doi.org/10.1016/j.amjmed.2010.05.020
https://doi.org/10.1016/j.amjmed.2010.05.020
Autor:
Alan D. Tice, Susan J. Rehm
Publikováno v:
Clinical Infectious Diseases. 51:S176-S182
The evolution of methicillin-resistant and vancomycin-resistant Staphylococcus aureus has demanded serious review of antimicrobial use and development of new agents and revised approaches to prevent and overcome drug resistance. Depending on local co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433265ad2ec955daa8de673be9855b2c
https://doi.org/10.1086/653518
https://doi.org/10.1086/653518
Autor:
Susan J. Rehm, Alan D. Tice
Publikováno v:
Clinical Infectious Diseases. 51:S171-S175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d32bf9cb67075a2635cdbf91004df20
https://doi.org/10.1086/653517
https://doi.org/10.1086/653517
Autor:
Bart Heeg, Alan D. Tice, Joseph C. Cappelleri, Jennifer M Stephens, Seema Haider, J. Floris S. Logman, Ben van Hout, Dilip Nathwani
Publikováno v:
Current Medical Research and Opinion. 26:1565-1578
With a growing number of studies and comparators in MRSA skin infections, a unified framework for comparing treatments is needed for health technology assessment (HTA). The objective was to systematically assess the success rates of common antimicrob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321249b1063a809184385fe1f10f3276
https://doi.org/10.1185/03007995.2010.481251
https://doi.org/10.1185/03007995.2010.481251
Autor:
Rockford G Yapp, Mark S. Sulkowski, Alan D. Tice, Stephen J. Rossi, Henry C. Bodenheimer, Herbert L. Bonkovsky, Alexander Monto
Publikováno v:
The American Journal of Gastroenterology. 103:2757-2765
Adherence to chronic hepatitis C (CHC) treatment may be particularly challenging in methadone maintenance patients. We assessed the safety, tolerability, and efficacy of peginterferon alfa-2a/ribavirin treatment in methadone maintenance patients prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1b951d873d4062317ce49abc3545c4
https://doi.org/10.1111/j.1572-0241.2008.02065.x
https://doi.org/10.1111/j.1572-0241.2008.02065.x
Autor:
Benjamin A. Lipsky, Alan D. Tice, Jasmanda Wu, Robin S. Turpin, Murray A. Abramson, Christopher T. Hoey
Publikováno v:
American Journal of Health-System Pharmacy. 64:1080-1086
Purpose. To evaluate potential cost savings, trial data were used to determine the clinical outcomes for i.v. ertapenem given once daily and i.v. piperacillin–tazobactam given every six hours daily in treating diabetic foot infections. Methods. A c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e106b43318461fceab4a0a264a2d3c
https://doi.org/10.1093/ajhp/64.10.1080
https://doi.org/10.1093/ajhp/64.10.1080